Matches in Wikidata for { <http://www.wikidata.org/entity/Q86169602> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q86169602 description "clinical trial" @default.
- Q86169602 description "ensayu clínicu" @default.
- Q86169602 description "klinisch onderzoek" @default.
- Q86169602 description "клінічне випробування" @default.
- Q86169602 name "Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (2012-03-31)" @default.
- Q86169602 name "Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (2012-03-31)" @default.
- Q86169602 type Item @default.
- Q86169602 label "Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (2012-03-31)" @default.
- Q86169602 label "Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (2012-03-31)" @default.
- Q86169602 prefLabel "Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (2012-03-31)" @default.
- Q86169602 prefLabel "Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area (2012-03-31)" @default.
- Q86169602 P1132 Q86169602-268DA078-8893-4810-ABDB-61ACA4A04B03 @default.
- Q86169602 P1476 Q86169602-82BB014D-EF20-4BFF-A78B-085B0C5EEB54 @default.
- Q86169602 P17 Q86169602-0F855C17-A46F-4DA0-AE25-697690B535AA @default.
- Q86169602 P17 Q86169602-58925BF9-8397-45DD-919C-9BF4264B3E58 @default.
- Q86169602 P2899 Q86169602-D004BA84-719F-47A6-8BC3-2BA2D0B952A3 @default.
- Q86169602 P3098 Q86169602-C1639068-BA4B-48B4-8C86-396302A6D5B6 @default.
- Q86169602 P31 Q86169602-39554ACA-5091-49C1-BE33-81E3985CD95F @default.
- Q86169602 P4135 Q86169602-2CCD2CB4-7A04-4AEC-978E-B647F5DC01B2 @default.
- Q86169602 P4844 Q86169602-AA58EEED-7BCB-4775-98FB-E55093E234D8 @default.
- Q86169602 P580 Q86169602-B8B1136D-ABF1-4EEE-B8B5-3D701CAA5F38 @default.
- Q86169602 P582 Q86169602-67F173DF-6051-4835-ACDB-36B529B72D62 @default.
- Q86169602 P6099 Q86169602-49C35C4E-FF9A-4C71-B371-7E53831E67DB @default.
- Q86169602 P8363 Q86169602-678FE212-C48C-46FC-8011-9BB6C90BCA8D @default.
- Q86169602 P1132 "+516" @default.
- Q86169602 P1476 "Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of ATX-101 (Sodium Deoxycholate Injection) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area" @default.
- Q86169602 P17 Q16 @default.
- Q86169602 P17 Q30 @default.
- Q86169602 P2899 "+18" @default.
- Q86169602 P3098 "NCT01546142" @default.
- Q86169602 P31 Q30612 @default.
- Q86169602 P4135 "+65" @default.
- Q86169602 P4844 Q425680 @default.
- Q86169602 P580 "2012-03-01T00:00:00Z" @default.
- Q86169602 P582 "2013-05-01T00:00:00Z" @default.
- Q86169602 P6099 Q42824827 @default.
- Q86169602 P8363 Q78089383 @default.